Lloyd Advisory Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$225K Buy
9,335
+8,664
+1,291% +$227K 0.09% 104
2026
Q1
$18.8K Sell
671
-7,930
-92% -$211K 0.01% 397
2025
Q4
$214K Sell
8,601
-125
-1% -$3.15K 0.08% 112
2025
Q3
$222K Buy
+8,726
New +$215K 0.1% 88
2024
Q2
Sell
-22,685
Closed -$629K 170
2024
Q1
$629K Buy
22,685
+12,915
+132% +$358K 0.13% 116
2023
Q4
$281K Sell
9,770
-16,697
-63% -$505K 0.13% 93
2023
Q3
$878K Buy
+26,467
New +$936K 0.29% 81
2022
Q4
$254K Buy
4,951
+75
+2% +$3.6K 0.18% 41
2022
Q3
$213K Sell
4,876
-2,450
-33% -$119K 0.16% 43
2022
Q2
$384K Buy
7,326
+3,030
+71% +$154K 0.3% 37
2022
Q1
$222K Buy
4,296
+1,274
+42% +$66.1K 0.1% 83
2021
Q4
$178K Sell
3,022
-726
-19% -$36K 0.08% 97
2021
Q3
$161K Sell
3,748
-2,989
-44% -$132K 0.08% 97
2021
Q2
$264K Buy
6,737
+750
+13% +$29.2K 0.13% 61
2021
Q1
$217K Sell
5,987
-105
-2% -$3.73K 0.12% 58
2020
Q4
$224K Sell
6,092
-883
-13% -$32.4K 0.12% 47
2020
Q3
$243K Sell
6,975
-948
-12% -$33.2K 0.15% 44
2020
Q2
$246K Sell
7,923
-898
-10% -$30.5K 0.15% 45
2020
Q1
$273K Sell
8,821
-1,492
-14% -$50.8K 0.2% 38
2019
Q4
$383K Buy
+10,313
New +$367K 0.35% 37

Other funds holding PFE

Lloyd Advisory Services's PFE Position: Q2 2026 in Review

Lloyd Advisory Services increased its Pfizer (PFE) stake by 1,291% in Q2 2026, buying an estimated $227K and bringing the position to 9,335 shares worth $225K. The position accounts for 0.09% of the portfolio, ranked #104.

Lloyd Advisory Services first reported a position in PFE in Q4 2019 and has held it in 20 quarters since. The position peaked at $878K in Q3 2023. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Lloyd Advisory Services held 9,335 shares of Pfizer worth $225K as of Q2 2026.
  • Lloyd Advisory Services bought 8,664 Pfizer shares in Q2 2026, an estimated $227K.
  • Pfizer made up 0.09% of Lloyd Advisory Services's portfolio in Q2 2026, its #104 holding.
  • Lloyd Advisory Services first reported a position in Pfizer in Q4 2019 and has held it in 20 quarters since.
  • Lloyd Advisory Services's Pfizer position peaked at $878K in Q3 2023.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Lloyd Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.